VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ARTVArtiva Biotherapeutics, Inc.
$9.36$231M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksARTVPrice History

ARTV logoArtiva Biotherapeutics, Inc. (ARTV) Stock Price History

Historical prices from 2024 to 2026

$9.36-0.46  (-4.68%)close Jun 22
Returns
1M
+6.5%
3M
+69.3%
YTD
+132.2%
1Y
+484.5%
3Y
-6.5%
5Y
-3.9%
ATH$17.31Oct 2024-45.9%
ATL$1.47Jun 2025pre-split
Avg Vol (50D)610K/ day
52-Week Range$1.47 — $14.53
LowCurrent: $9.36High

Loading 10-year price history...

ARTV Historical Performance

1 YearTotal Return
+484.5%
Price: +484.5%
3 YearsTotal Return
-18.2%
CAGR: -6.5%
Price: -18.2%
5 YearsTotal Return
-18.2%
CAGR: -3.9%
Price: -18.2%
YTD
+132.2%

ARTV Annual Returns

Year-by-year price performance · 2024–2026

Best-16.0%2024
Worst-57.0%2025
Up years1/3
2024-16.0%
2025-57.0%
2026+37.6%
2024 annual price return
-16.0%
2025 annual price return
-57.0%
2026 annual price return
+37.6%
LessMore
Alpha vs S&P 500
1Y+459.5%
3Y-25.6%
5Y-16.2%

Price returns only.

Download Historical Data

483 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ARTV Stock Price Trajectory (2024–2026)

As of June 23, 2026, Artiva Biotherapeutics, Inc. (ARTV) trades at $9.36, representing a +484.5% return over the past year. The stock has delivered a -18.2% total return over five years (-3.9% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $17.31 on October 1, 2024. From this peak, ARTV has corrected -45.9%, currently trading 70% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers FATE (+72.7% 1Y), NKTR (+608.2% 1Y), and STTK (+408.0% 1Y), ARTV has underperformed the peer group average. Compare ARTV vs FATE →

ARTV Historical Price Data · from 2024

Rows 1–50 of 483
Date Open High Low Close Volume Change %
2026-06-229.9210.009.339.36461K-4.68%
2026-06-1810.0010.509.489.821.41M-1.21%
2026-06-179.4210.469.119.94949K+11.56%
2026-06-169.149.238.548.91777K-2.94%
2026-06-158.579.768.529.18117K+7.49%
2026-06-128.618.838.118.541.43M+6.75%
2026-06-117.428.017.278.001.06M+7.82%
2026-06-107.807.856.967.42492K+2.06%
2026-06-096.777.426.747.27967K+6.91%
2026-06-087.317.496.706.80580K-0.73%
2026-06-057.657.676.796.85356K-10.81%
2026-06-046.847.796.847.68310K+10.19%
2026-06-036.957.446.716.97491K+1.46%
2026-06-027.437.506.756.87590K-7.91%
2026-06-017.958.047.467.46288K-5.93%
2026-05-298.428.427.447.93704K+4.20%
2026-05-287.627.787.457.61212K-0.26%
2026-05-277.528.017.527.63308K-0.52%
2026-05-268.008.187.617.67305K-2.54%
2026-05-227.978.137.717.87307K-1.50%
2026-05-217.838.417.737.99423K+1.91%
2026-05-208.849.047.757.841.05M-8.30%
2026-05-199.009.338.378.55845K-7.27%
2026-05-189.9610.178.919.22516K-5.73%
2026-05-1510.6010.729.609.78522K-8.43%
2026-05-1411.3811.5010.2510.68384K+1.71%
2026-05-1310.6710.9310.2410.50423K-1.22%
2026-05-1211.0011.6610.4910.63521K+0.28%
2026-05-1111.6811.6810.4310.60863K-2.66%
2026-05-0812.0512.6810.2010.895.27M-13.02%
2026-05-0712.2912.5712.0012.52152K+1.05%
2026-05-0611.3113.0011.0012.39307K+16.89%
2026-05-0511.1611.3710.5310.60145K-6.11%
2026-05-0410.8211.5210.6011.29110K+4.54%
2026-05-0110.0211.069.8810.80194K+5.47%
2026-04-308.9210.528.7510.24240K+17.43%
2026-04-299.049.338.528.72242K-4.60%
2026-04-2810.4410.608.669.14275K-14.98%
2026-04-2710.1811.4210.0110.75117K+4.17%
2026-04-2411.4211.6310.2410.32151K-8.67%
2026-04-2311.4511.9910.9511.30170K-3.67%
2026-04-2212.5012.7910.5111.73393K-5.25%
2026-04-2113.5013.5011.8512.38501K-7.54%
2026-04-2012.5114.5312.1113.39638K+6.69%
2026-04-1712.6813.1611.1112.55743K+3.63%
2026-04-168.9812.398.9312.111.27M+33.08%
2026-04-157.889.147.719.10875K+21.50%
2026-04-147.257.927.107.49227K+4.32%
2026-04-136.837.306.837.18223K+5.43%
2026-04-106.846.976.626.81121K+0.15%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ARTV — Frequently Asked Questions

Quick answers to the most common questions about buying ARTV stock.

How has ARTV stock performed recently?

ARTV returned +484.5% over the past year, beating its 5-year annualized CAGR of -3.9%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ARTV's all-time high price?

Artiva Biotherapeutics, Inc. reached $17.31 on 2024-10-01. The 52-week high is $14.53. Current 1-year return of +484.5% places the stock closer to historical peaks.

Where can I download ARTV historical price data?

This page provides ARTV daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.

483 data points